Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: A cause for clinical concern

Journal of Psychopharmacology

Volumn 23, Issue 1, 2009, Pages 6-13

  Mukhopadhaya, K ^a,b   Krishnaiah, R ^a,b   Taye, T ^a,b   Nigam, A ^a,b   Bailey, A J ^a,b   Sivakumaran, T ^c   Fineberg, N A ^a,b,c  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^b HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Clozapine; OCD; Schizophrenia

Indexed keywords

AMISULPRIDE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; LITHIUM; MOCLOBEMIDE; PAROXETINE; PIRENZEPINE; PROCYCLIDINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; VALPROIC ACID; VENLAFAXINE; ZOPICLONE;

ADULT; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INVOLUNTARY MOVEMENT; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 58649121660     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089582     Document Type: Article

References (63)

1. Allen, L., Tejera, C. (1994) Treatment of clozapine-induced obsessive compulsive symptoms with sertraline. Am J Psychiatry 151: 1096-1097.
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, version IV. Washington DC: APA.
3. Baker, RW, Roy Chengappa, KN, Baird, JW, Steingard, S., Christ, MAG, Schooler, NR (1992) Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53: 439-442.
4. Barnes, TR (1989) A rating scale for drug induced akathisia. Br J Psychiatry 154: 672-676.
5. Berman, I., Kalinoswski, A., Berman, SM, Lengua, G., Green, AI (1995 a) Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry 36: 6-10.
6. Berman, I., Merson, A., Viegner, B., Losonczy, MF, Pappas, D., Green, AI (1998) Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis 186: 150-156.
7. Berman, I., Sapers, BL, Chang, HH, Lasonczy, MF, Schmildler, J., Green, AI (1995 b) Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 15: 206-210.
8. Biondi, M., Fedele, L., Arcangeli, T., Pancheri, P. (1999) Development of obsessive compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychother Psychosom 68: 111-112.
9. Bland, RC, Newman, SC, Orn, H. (1987) Scizophrenia: lifetime comorbidity in a community sample. Acta Psychiatr Scand 75: 383-391.
10. Bleuler, E. (1911) Dementia praecox oder Gruppe der Schizophrenien [Dementia praecox or the group of schizophrenias]. In: Aschaffenburg, G, (ed). Handbuch der Psychiatrie, Spez. Teil, 4 Abt, Leipzig, Deuticke.
11. Bleuler, E. (1956) Dementia Praecox in the Group of Schizophrenias. New York International University Press.
12. Byerly, M., Goodman, W., Acholonu, W., Bugno, R., John Rush, A. (2005) Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res 76: 309-316.
13. Conley, RR, Kelly, DL (2005) Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci 42: 51-60.
14. De Haan, L., Linszen, D., Gorsira, R. (1999) Clozapine and obsessions in patients with recent onset schizophrenia and other psychotic disorder. J Clin Psychiatry 60: 364-365.
15. De Haan, L., Oekeneva, A., Van Amelsvoort, T., Linszen, D. (2004) Obsessive compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry 19: 524.
16. Dwivedi, S., Pavuluri, M., Heidenreich, J., Wright, T. (2002) Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia. J Child Adolesc Psychopharmacol 12: 69-70.
17. Eisen, JL, Beer, DA, Pato, MT, Venditto, TA, Rasmussen, SA (1997) Obsessive-compulsive disorder in patients with scizhophrenia or scizoaffective disorder. Am J Psychiatry 154: 271-273.
18. Ertugrul, A., Anil, YAE, Eni, N., Yazici, KM, Yagcioglu, AE (2005) Obsessive-compulsive symptoms in clozapine treated schizophrenic patients. Psychiatry Clin Neurosci 59: 219-222.
19. Fenton, WS, McGlashan, TH (1986) The prognostic significance of obsessive compulsive symptoms in schizophrenia. Am J Psychiatry 143: 437-441.
20. Fineberg, NA, Gale, TM (2005) Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 8: 107-129.
21. Fineberg, NA, Gale, T., Sivakumaran, T. (2006) A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol 20: 97-103.
22. Galvez-Buccollini, JA, Fiestas, F., Herrera, P., Vega-Dienstmaier, JM, Guimas, B., Mazzotti, G. (2004) Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs. Actas Esp Psiquiatr 32: 211-215.
23. Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C., Fleischman, R., Hill, C., Heninger, GR, Charney, DS (1989) The Yale-Brown Obsessive-Compulsive Scale: I, development, use, and reliability. Arch Gen Psychiatry 46: 1006-1011.
24. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology (revised ed). Washington: US Department of Health, Education, and Welfare.
25. Haro JM, Kamath, SA, Ochoa, S, Novick, D, Rele, K, Fargas, A, Rodriguez, MJ, Rele, R, Orta, J, Kharbeng, A, Araya, S, Gervin, M, Alonso, J, Mavreas, V, Lavrentzou, E, Liontos, N, Gregor, K, Jones, PB. ; SOHO Study Group (2003) The Clinical Global Impression Schizophrenia Scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand (Suppl. 416). 16-23.
26. Hollander, E., Kaplan, A., Schmeidler, J., Yang, H., Li, D., Koran, LM, Barbato, LM (2005) Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 17: 472-477.
27. Hwang, MY, Hollander, E. (1993) Schizo-obsessive disorders. Psychiatr Ann 23: 396-401.
28. Hwang, MY, Morgan, JE, Losconzcy, MF (2000) Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci 12: 91-94.
29. Iqbal, MM, Rahman, A., Husain, Z., Mahmud, SZ, Ryan, WG, Feldman, JM (2003) Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 15: 33-48.
30. Kruger, S., Braunig, P., Hoffler, J., Shugar, G., Borner, I., Langkrar, J. (2000) Prevalence of obsessive compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci 12: 16-24.
31. Leon, AC, Shear, MK, Portera, L., Klerman, GL (1992) Assessing impairment in patients with panic disorders: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 27: 78-82.
32. Lykouras, L., Alevizos, B., Michalopoulou, P., Rabavilas, A. (2003) Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 27: 333-346.
33. Lysaker, PH, Bryson, GJ, Marks, KA, Greig, TC, Bell, MD (2002) Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. J Neuropsychiatry Clin Neurosci 14: 449-453.
34. Lysaker, PH, Marks, KA, Picone, JB, Rollins, AL, Fastenau, PS, Bond, GR (2000) Obsessive and compulsive symptoms in schizophrenia. J Nerv Ment Dis 188: 78-83.
35. Ma, N., Tan, LW, Wang, Q., Li, ZX, Li, LJ (2007) Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Psychiatry Res 150: 61-69.
36. McDougle, CJ, Epperson, CN, Pelton, GH, Wasylink, S., Price, LH (2000) A double-blind placebo-controlled study of risperidone addition in serotonin reuptake inhibitor refractory obsessive compulsive disorder. Arch Gen Psychiatry 57: 794-801.
37. Nechmad, A., Ratzoni, G., Poyurovsky, M., Meged, S., Avidan, G., Fuchs, C., Bloch, Y., Weizman, R. (2003) Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry 160: 1002-1004.
38. Niehaus, DJH, Koen, L., Muller, J., Laurent, C., Stein, DJ, Lochner, C., Seedat, S., Mbanga, I., Deleuze, JF, Mallet, J., Emsley, RA (2005) Obsessive compulsive disorder-prevalence in Xhosa-speaking schizophrenia patients. S Afr Med J 95: 120-122.
39. Ohta, N., Kokai, M., Morita, Y. (2003) Features of obsessive disorder in patients primarily diagnosed with schizophrenia. Psychiatry Clin Neurosci 57: 67-74.
40. Ongur, D., Goff, DC (2005) Obsessive compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res 75: 349-362.
41. Ozer, S., Arsava, M. Erturul, A., Demir, B. (2006) Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiat 30: 724-727.
42. Pallanti, S., Quercioli, L., Rossi, A. (2006) Prevalence, diagnosis and long-term treatment of obsessive-compulsive symptoms in schizophrenia. Adv Schizophr Clin Psychiatry 2: 38-44.
43. Porto, L., Bermanzohn, PC, Pollack, C., Morrissey, R., Siris, SG (1997) A profile of obsessive compulsive symptoms in schizophrenia. CNS Spectr 2: 21-25.
44. Poyurovsky, M., Dorfman-Etrog, P., Hermesh, H., Munitz, H., Tollefson, GD, Weizman, A. (2000) Beneficial effect of olanzapine in schizophrenic patients with obsessive compulsive symptoms. Int Clin Psychopharmacol 15: 169-173.
45. Poyurovsky, M., Fuchs, C., Weizman, A. (1999 a) Obsessive compulsive disorder in patients with first-episode schizophrenia. Am J Psychiatry 156: 1998-2000.
46. Poyurovsky, M., Hermesh, H., Weizman, A. (1996) Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clin Neuropharmacol 19: 305-313.
47. Poyurovsky, M., Hramenkov, S., Isakov, V., Rauchverger, B., Modai, I., Schneidman, M., Fuchs, C., Weizman, A. (2001) Obsessive-compulsive disorder in hospitalised patients with chronic schizophrenia. Psychiatry Res 102: 49-57.
48. Poyurovsky, M., Isakov, V., Hromnikov, S., Modai, I., Rachberger, B., Schneidman, M., Weizman, A. (1999 b) Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 14: 95-100.
49. Poyurovsky, M., Kriss, V., Weisman, G., Faragian, S., Kurs, R., Schneidman, M., Fuchs, C., Weizman, A., Weizman, R. (2003) Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry 64: 1300-1307.
50. Poyurovsky, M., Weizman, A. (1998) Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms. Am J Psychiatry 155: 993.
51. Rahman, MS, Grace, JJ, Pato, MT, Priest, B. (1998) Sertraline in the treatment of clozapine-induced obsessive-compulsive behaviour. Am J Psychiatry 155: 1626.
52. Reznik, I., Sirota, P. (2000) Obsessive and compulsive symptoms in schizophrenia: a randomised controlled trial with fluvoxamine and neuroleptics. J Clin Psychopharmacol 20: 410-416.
53. Reznik, I., Yavin, I., Stryjer, R., Spivak, B., Gonen, N., Strous, R., Mester, R., Weizman, A., Kotler, M. (2004) Clozapine in the treatment of obsessive compulsive symptoms in schizophrenia patients: a case series study. Pharmacopyschiatry 37: 52-56.
54. Sheehan, DV, Lecrubier, Y., Sheehan, KH, Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl. 20). 22-23 ; quiz 34-37.
55. Sievers, M., Sato, T., Moller, HJ, Bottlender, R. (2005) Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI. Pharmacopsychiatry 38: 104-105.
56. Simpson, GN, Angus, JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212 (Suppl. 44). 11-19.
57. Strejilevich, SA, Palatnik, A., Avila, R., Bustin, J., Cassone, J., Figueroa, S., Gimenez, M., de Erausquin, GA (2005) Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Res 133: 277-280.
58. Strous, RD, Patel, JK, Zimmet, S., Green, AI (1999) Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. Am J Psychiatry 156: 973-974.
59. Tibbo, P., Kroetsch, M., Chue, P., Warneke, L. (2000) Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 34: 139-146.
60. Tibbo, P., Warneke, L. (1999) Obsessive-compulsive disorder in schizophrenia: epidemiological and biologic overlap. J Psychiatry Neurosci 24: 15-24.
61. Whitney, KA, Fastenau, PS, Evans, JD, Lysaker, PH (2004) Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophr Res 69: 75-83.
62. Wykes, T., Sturt, E. (1986) The measurement of social behaviour in psychiatric patients: an assessement of the reliability and validity of the SBS schedule. Br J Psychiatry 148: 1-11.
63. Zohar, J., Kaplan, Z., Benjamin, J. (1993) Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 54: 385-388.